Quince Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:QNCX

Comments

Quince Therapeutics Inc Earnings Estimates

QNCXNASDAQ

Trade with Public

$0.1831

0.020112.33%

At close: Apr 8, 5:00 PM EST

$0.1757

-0.0074-4.04%

After Hours: 7:59 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Quince Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:QNCX

Quince Therapeutics (QNCX) is scheduled to report Q4 earnings on April 21, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of N/A.

In the most recent quarter (Q3), Quince Therapeutics reported EPS of $-0.25, missing estimates of $-0.21 by 0.19%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Quince Therapeutics has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Quince Therapeutics has averaged an EPS surprise of 0.71% and a revenue surprise of 0.00%.

Earnings Date

Apr 21

EPS Estimate

$-0.210

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–

Quince Therapeutics Earnings History

Analyze the earnings history of Quince Therapeutics using advanced sorting and filters.

Loading calendar...

Quince Therapeutics (QNCX) Earnings Per Share

The chart below shows Quince Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Quince Therapeutics (QNCX) Revenue

The chart below shows Quince Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Quince Therapeutics (NASDAQ:QNCX) reporting earnings?

Quince Therapeutics (QNCX) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.

What were the latest earnings per share (EPS) for Quince Therapeutics (NASDAQ:QNCX)?

The Actual EPS was $-0.25, which missed the estimate of $-0.21.

What were Quince Therapeutics’s (NASDAQ:QNCX) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Acurx Pharmaceuticals Inc

NASDAQ:ACXP

$2.92

-1.35%

Quoin Pharmaceuticals Ltd

Cellectar Biosciences Inc

Bolt Biotherapeutics Inc

NASDAQ:BOLT

$4.96

7.83%

AlphaTON Capital Corp

Quince Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:QNCX

Quince Therapeutics (QNCX) is scheduled to report Q4 earnings on April 21, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of N/A.

In the most recent quarter (Q3), Quince Therapeutics reported EPS of $-0.25, missing estimates of $-0.21 by 0.19%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Quince Therapeutics has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Quince Therapeutics has averaged an EPS surprise of 0.71% and a revenue surprise of 0.00%.

Earnings Date

Apr 21

EPS Estimate

$-0.210

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–